During the past decade, Ordination Dr. Wette conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ordination Dr. Wette" #1 collaborator was "Amgen" with 2 trials as a collaborator, "AstraZeneca" with 2 trials as a collaborator, "Hoffmann-La Roche" with 2 trials as a collaborator, "Bayer" with 1 trials as a collaborator and "Ebewe Pharma GmbH" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Ordination Dr. Wette" are "Breast Cancer" (2 trials), "Circulating Tumor Cells" (1 trials) and "Synchronous Metastasized Breast Cancer" (1 trials). Many other conditions were trialed in "Ordination Dr. Wette" in a lesser frequency.

Most popular intervention types in "Ordination Dr. Wette" are "Drug" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Capecitabine" (1 trials), "Docetaxel" (1 trials), "Epirubicin" (1 trials), "Surgery" (1 trials) and "Surgery on Demand" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ordination Dr. Wette" are 3 trials for "Female" genders.

Currently, there are NaN active trials in "Ordination Dr. Wette". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Ordination Dr. Wette, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Ordination Dr. Wette, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".